On Milestone Anniversary, HPC Calls on Incoming Administration and Legislature To Take Immediate Action To Confront Health Care Affordability
HPC Board Approves Mass General Brigham Performance Improvement Plan
Inaugural HPC Board Chair Dr. Stuart Altman To Step Down After 10 Years
BOSTON — Dr. Stuart Altman announced today that he is stepping down from the Massachusetts Health Policy Commission’s Board of Commissioners, effective July 13, 2022.
HPC Receives Performance Improvement Plan Proposal From Mass General Brigham
First-ever PIP required by HPC to address health care spending concerns
HPC Finds Mass General Brigham Cost Trends and Expansions Threaten State Health Care Affordability Efforts
HPC requires MGB to develop public performance improvement plan to reduce cost growth; Proposed MGB expansions would further increase commercial health care spending by at least $46 million to $90 million per year
HPC Reflects on Challenges and Opportunities in the Health Care System at Annual Cost Trends Hearing
Addressing affordability challenges for residents, health inequities, and the future of the health care workforce identified as priority areas for future policy action
HPC Releases 2022 Public Meeting and Event Calendar
The agency is slated to host 15 public meetings and events in 2022, including the 10th Annual Health Care Cost Trends Hearing
HPC Announces Mandatory COVID-19 Vaccine Requirement for All Employees
Employees are required to provide proof of vaccination by October 26, 2021
HPC Awards $400,000 To Combat Racial Inequities in Maternal Health
Programs will provide patients with care from doulas in their communities or with shared lived experience of inequities
New HPC Report Identifies Key Health Care Cost Drivers and Calls for Immediate Action To Confront Pressing Affordability Challenges Facing the Commonwealth
Recommendations take aim at excessive provider prices, health plan affordability, and persistent health inequities
HPC Issues Statement on Preliminary Review of Atrius-Optum Transaction
BOSTON — Statement from the Massachusetts Health Policy Commission on its preliminary review of the Atrius-Optum transaction:
“Yesterday, the HPC notified Atrius Health and Optum that it has completed the preliminary review of their proposed transaction and has elected not to proceed to a full cost and market impact review (CMIR). During its review, the HPC examined the potential impact of the acquisition on health care spending and market functioning in Massachusetts using available data and information.